Has Britain got its booster strategy WRONG?

11:30pm, Monday, 06'th Dec 2021 Daily Mail Online
A first dose of AstraZeneca followed by a second dose of Moderna or Novavax induces more antibodies and T-cells than two AstraZeneca injections, Oxford University researchers found.

GlaxoSmithKline Makes Another Big Bet on Brain Drugs

10:46pm, Monday, 06'th Dec 2021 GuruFocus
Company''s deal with Oxford University follows July pact with Alector Check out Paul Singer Stock Picks » Download GuruFolio Report of Paul Singer (Updated on 12/05/2021) Related Stocks: GSK , ALEC , PPH , PFE , LLY , AZN , BMY , ME ,

Pfizer accused of sabotaging AstraZeneca jab

10:31pm, Monday, 06'th Dec 2021 Russia Today
US drugmaker Pfizer is denying any wrongdoing after a British TV documentary showed a presentation on its behalf had criticized the rival Covid-19 vaccine AstraZeneca as potentially dangerous and unsafe. Read Full Article at RT.com

Orola slams jabs wasted by province

06:42pm, Monday, 06'th Dec 2021 Visayan Daily Star
The recent fiasco involving the expiration of AstraZeneca vaccines in the Provincial Health Office Cold Room facility is reeking with gross negligence and arrogance, a press release from gubernatorial aspirant Jon Orola said yesterday. Provincial Administrator Rayfrando Diaz II, told The post Orola slams jabs wasted by province appeared first on Visayan Daily Star .
45,294 doses of Pfizer, Moderna, AstraZeneca and Johnson & Johnson vaccines have been administered in the last 24 hours, of which 10,587 the first dose, 14,101 - the second dose and 20,606 - the third dose, the National Coordinating Committee for Activities on Vaccination against Citete mai departe
Vit Nam has received over 150 million doses of COVID-19 vaccines, with Sinopharm, AstraZeneca and Pfizer accounting for the majority.
Should investors be watching these biotech stocks with all the current focus on the Omicron Covid variant?

Futures Rebound From Friday Rout As Omicron Fears Ease

12:51pm, Monday, 06'th Dec 2021 Zero Hedge
Futures Rebound From Friday Rout As Omicron Fears Ease S&P futures and European stocks rebounded from Fridays selloff while Asian shares fell, as investors took comfort in reports from South Africa which said initial data doesnt show a surge of hospitalizations as a result of the omicron variant, a view repeated by Anthony Fauci on Sunday. Meanwhile, fears about a tighter Fed were put on the backburner. Also overnight, Chinas central bank announced it will cut the RRR by 50bps releasing 1.2tn CNY in liquidity, a move that had been widely expected. The cut comes as insolvent Chinese property developer Evergrande was said to be planning to include all its offshore public bonds and private debt obligations in a restructuring plan. US equity futures rose 0.3%, fading earlier gains, and were last trading at 4,550. Nasdaq futures pared losses early in the U.S. morning, trading down 0.4%. Oil rose after Saudi Arabia boosted the prices of its crude, signaling confidence in the demand outlook, which helped lift European energy shares.
Onyx Bridge Wealth Group LLC purchased a new stake in shares of AstraZeneca PLC (NASDAQ:AZN) in the third quarter, according to its most recent filing with the SEC. The firm purchased 4,070 shares of the companys stock, valued at approximately $241,000. Other hedge funds also recently bought and sold shares of the company. 44 Wealth []

AstraZenecas (AZN) Buy Rating Reiterated at Liberum Capital

12:00pm, Monday, 06'th Dec 2021 Dakota Financial News
AstraZeneca (LON:AZN)s stock had its buy rating reissued by research analysts at Liberum Capital in a note issued to investors on Monday, Digital Look reports. Other research analysts have also issued research reports about the stock. Deutsche Bank Aktiengesellschaft restated a buy rating and set a £105 ($137.18) price target on shares of AstraZeneca in []
Governments must begin preparation now for a more lethal pandemic, the creator of the Oxford/AstraZeneca vaccine has warned.

Next pandemic could be worse, warns AstraZeneca vaccine co-creator

11:44am, Monday, 06'th Dec 2021 The Bobr Times
MISE & Agrave; DAY London | A next pandemic is likely to be worse, will warn on Monday the British scientist Sarah Gilbert, co-creator of the Oxford/AstraZeneca vaccine against COVID-19, calling for investment in research to be better prepared for this eventuality. & nbsp; This won''t be the last time a virus threatens our lives [] The post Next pandemic could be worse, warns AstraZeneca vaccine co-creator first appeared on The Bobr Times .

Scientist says next pandemic may be worse

11:31am, Monday, 06'th Dec 2021 Perth Now
A scientist behind the AstraZeneca COVID-19 vaccine says the next pandemic may be more lethal unless funds are devoted to research and planning.
The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Antidepressants market. It includes Porters Five Forces and PESTLE analysis

Expert Warns The Next Virus Could Be More Contagious & More Lethal

10:05am, Monday, 06'th Dec 2021 Your News Wire
The Oxford professor who created the AstraZeneca vaccine has warned that the next pandemic could be even more deadly than the current covid virus crisis, which is far from over. According to Professor Dame Sarah [] The post Expert Warns The Next Virus Could Be More Contagious & More Lethal appeared first on News Punch .
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE